Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp.- Full Release
Picard Med ...
Picard Medical acquires SynCardia Systems Inc, the leader in Total Artificial Heart (“TAH”) technology
Hunniwell ...
A Robotic-Assisted Surgery (RAS) Review: Clinical Landscape, Commercial Arena, and Future Outlook
Hunniwell ...
CoapTech Awarded $1.6 Million from NIH for PUMA System
Hunniwell's Series B Investment CoapTech was recently awarded $1.6 Million from NIH to finalize the development and trial of its Pediatric PUMA-G System.
ViviMedia Interviews Richard Fang at F50 Global Capital Summit
HLV Founding Managing Partner Richard Fang shares his personal entrepreneurial experience, as well as the motivation and the differentiating strategies behind the Hunniwell Medical Device Fund.
WaveClear Raises $1.125 Million in Series A Funding Led by Hunniwell
WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications.
CoapTech Raises $7M in Series B Funding Led by Hunniwell
CoapTech has closed a Series B investment of $7 million led by Hunniwell. The funds will be used to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.
Hunniwell at the Spring 2020 F50 Global Capital Summit
Hunniwell Lake Ventures (HLV) is pleased to sponsor this year’s Spring F50 Global Capital Summit, June 16-17, 2020. Watch HLV partners give talks, host live roundtables, speak on panels and judge startups.
Four Industry Veterans Join Hunniwell
Hunniwell Lake Ventures is pleased to gain the strategic counsel of these talented, highly experienced and successful professionals - David Schechter, David Cao, John Ashley and Matt Otten - as they help us achieve our mission towards Intelligent Surgery.
